Detrusin LA Capsule 4 mg contains Tolterodine Tartrate 4 mg, a long-acting antimuscarinic agent designed to manage overactive bladder (OAB) symptoms. Tolterodine works by selectively blocking muscarinic receptors in the bladder’s detrusor muscle, reducing involuntary contractions, increasing bladder capacity, and helping control urinary urgency, frequency, nocturia (nighttime urination), and urge incontinence.

Overactive bladder is a common condition characterized by frequent and sudden urges to urinate, often accompanied by leakage and disruption of daily activities. These symptoms can significantly affect quality of life, sleep, and emotional well-being. Detrusin LA Capsule 4 mg provides sustained, once-daily symptom relief, ensuring consistent control of bladder activity throughout the day and night.

The long-acting formulation maintains stable blood concentrations of tolterodine, reducing fluctuations that can cause side effects while providing optimal therapeutic benefits. It is suitable for adults requiring higher doses for effective OAB management, particularly in patients who have insufficient response to the 2 mg dose.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Detrusin LA Capsule 4 mg is indicated for:

• Management of overactive bladder (OAB) with symptoms of urinary urgency, frequency, and urge incontinence

• Reduction of nocturia, improving nighttime sleep quality

• Patients requiring higher-dose therapy for persistent or severe OAB symptoms

Key Benefits

• Reduces involuntary bladder contractions, controlling urgency and frequency

• Helps prevent urinary leakage and episodes of urge incontinence

• Improves quality of sleep by decreasing nighttime urination

• Long-acting, once-daily formulation enhances adherence and convenience

• Supports better daily functioning and overall patient comfort

Mechanism of Action

Tolterodine Tartrate is an antimuscarinic agent that selectively binds to muscarinic M2 and M3 receptors in the detrusor muscle of the bladder. These receptors mediate bladder contraction in response to acetylcholine. By blocking them, tolterodine reduces involuntary bladder contractions, allowing the bladder to fill and store urine more effectively. This mechanism helps decrease urinary urgency, frequency, and incontinence episodes without significantly impairing bladder emptying.

Dosage and Administration

• The standard dose for adults is 4 mg once daily, preferably in the morning.

• Capsules should be swallowed whole with water and may be taken with or without food.

• Dose adjustments may be necessary in patients with severe renal or hepatic impairment, as determined by a healthcare professional.

• Consistent daily use is recommended for maximum symptom control.

Precautions

• Use cautiously in patients with urinary retention, gastric retention, severe liver or kidney disease, or narrow-angle glaucoma.

• Monitor for common anticholinergic side effects such as dry mouth, constipation, and blurred vision.

• Inform the physician about all other medications to prevent potential drug interactions, especially other anticholinergic drugs.

• Not suitable for patients with known hypersensitivity to tolterodine or other antimuscarinics.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Detrusin LA Capsule 4 mg is generally well tolerated. Side effects may include:

• Dry mouth

• Constipation

• Headache

• Blurred vision

• Rarely, dizziness or urinary retention

Most side effects are mild, often transient, and may decrease with continued therapy. Dose adjustments can help minimize adverse effects.

Storage

Store below 30°C in a cool, dry place, protected from light and moisture. Keep out of reach of children.